vasoactive intestinal peptide receptor Vasoactive intestinal peptide - VIPR2 Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor Unveiling the Vasoactive Intestinal Peptide Receptor: A Deep Dive into Its Structure, Function, and Significance

Vasoactive intestinal peptideinjection The vasoactive intestinal peptide receptor, a critical component in cellular signaling, plays a pivotal role in numerous physiological processes throughout the body. These receptors are primarily known through two subtypes: VPAC1 and VPAC2作者：C Severi·2006·被引用次数：14—Vasoactive intestinal peptide (VIP) relaxes smooth muscle by interacting with receptors coupled to cAMP- or cGMP-signalling pathways.. Both are integral to the action of vasoactive intestinal peptide (VIP), a neuropeptide with a wide distribution that acts as a neuromodulator and neurotransmitter. Understanding the intricacies of the vasoactive intestinal peptide receptor is crucial for comprehending its involvement in everything from smooth muscle relaxation to immune responses and gastrointestinal homeostasisThere are two known receptors for the vasoactive intestinal peptide(VIP) termed VPAC1 and VPAC2. These receptors bind both VIP and pituitary adenylate ....

At its core, the vasoactive intestinal peptide receptor is a protein. Specifically, VPAC1 and VPAC2 are described as members of the secretin subclass of G protein-coupled receptorsVasoactive Intestinal Peptide/Pituitary Adenylate Cyclase .... These G protein-coupled receptors (GPCRs) are characterized by their unique structure, which includes seven transmembrane domains and an extracellular N-terminal domain.Therapeutic potential of vasoactive intestinal peptide and ... The VIPR1 gene encodes vasoactive intestinal peptide receptor 1, while VIPR2 encodes its counterpart. These genes are responsible for the synthesis of these vital signaling proteins. Research indicates that VPAC1 is the predominant receptor found in the colon, exhibiting higher levels compared to the small intestine, suggesting tissue-specific roles. Meanwhile, VPAC2 has been identified as the predominant receptor expressed in human thymocytes, highlighting its role in immune cell function.作者：X Hou·2022·被引用次数：15—Vasoactive intestinal peptide (VIP), a 28-amino-acid peptide,can stimulate glucose-dependent insulin secretion, particularly by binding to VPAC2 receptors.

The activation of the vasoactive intestinal peptide receptor by vasoactive intestinal peptide (also known as vasoactive intestinal polypeptide (VIP)) triggers a cascade of intracellular events. When vasoactive intestinal peptide binds to its receptor, it leads to signaling involving calcium ions. This interaction is often coupled to cAMP- or cGMP-signalling pathways, which are fundamental to cellular communication and function. The binding of VIP to receptors is known to trigger downstream effects such as smooth muscle relaxation.Expression and localization of VPAC1, the major receptor of ... In fact, vasoactive intestinal peptide(VIP) has potent relaxing effects on vascular and nonvascular smooth muscle, a key function contributing to its name. Furthermore, vasoactive intestinal peptide can also regulate water and ion flux from the lungs.

The physiological implications of vasoactive intestinal peptide receptor activity are far-reaching.2006年1月25日—Vasoactive Intestinal Peptide (VIP) Receptor Type 2 (VPAC2)is the Predominant Receptor Expressed in Human Thymocytes. MARIA L. LARA-MARQUEZ,. Vasoactive intestinal peptide itself plays many physiological roles in the peripheral and central nerve systems. It is a potent vasodilator, contributing to blood flow regulation. Beyond its role in smooth muscle, VIP sustains GIT homeostasis through the maintenance of the intestinal epithelial barrier and acts as a potent anti-inflammatory mediator, contributing to gut health. Research also suggests that vasoactive intestinal peptide can stimulate glucose-dependent insulin secretion, particularly by binding to VPAC2 receptors, indicating a role in metabolic regulation. The therapeutic potential of vasoactive intestinal peptide and its receptors is an active area of research, with potential applications in managing various inflammatory dermatoses like atopic dermatitis and psoriasis.

The presence of vasoactive intestinal peptide receptors is not limited to the nervous system and smooth muscleVasoactive Intestinal Polypeptide Receptor - an overview. They are widely distributed in different tissues or carcinoma cells originating from the endoderm. This broad distribution underscores the pervasive influence of VIP signaling.Vasoactive intestinal polypeptide Studies have investigated the expression and localization of these receptors in various cell types, including monocytes, and their involvement in different biological processes.

The scientific community has explored the nuances of VIP receptor pharmacology for decades. Early evidence suggested that VIP acts via multiple receptors, leading to the identification of distinct subtypes like VPAC1 and VPAC2Vasoactive intestinal polypeptide. These receptors are part of the secretin subclass of GPCRs, a family known for its diverse signaling capabilities. The characterization of vasoactive intestinal peptide receptor subtypes and their signaling pathways continues to be a focus of molecular pharmacology.

In summary, the vasoactive intestinal peptide receptor, primarily through its VPAC1 and VPAC2 subtypes, is a crucial element in the body's complex signaling network. These proteins expressed by astrocytes and found throughout various tissues are activated by vasoactive intestinal peptide, a peptide hormone that is vasoactive in the intestine and beyond. Their roles in smooth muscle relaxation, immune modulation, gastrointestinal health, and potentially metabolic regulation highlight their profound physiological significance. The ongoing exploration of vasoactive intestinal peptide receptor function and pharmacology promises further insights into human health and disease.Orbitofrontal cortex drives predictive filtering of sensory ...